Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0V8KA
|
||||
| Former ID |
DIB019575
|
||||
| Drug Name |
compound 7
|
||||
| Synonyms |
compound 7 [PMID: 20180624]
|
||||
| Drug Type |
Small molecular drug
|
||||
| Formula |
C11H9N5S
|
||||
| InChI |
InChI=1S/C11H9N5S/c1-2-4-12-10(3-1)16-11-15-9(7-17-11)8-5-13-14-6-8/h1-7H,(H,13,14)(H,12,15,16)
|
||||
| InChIKey |
WIILZWDTWZFGNO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Metabotropic glutamate receptor 4 | Target Info | Modulator (allosteric modulator) | [531039] | |
| References | |||||
| Ref 530747 | mGluR4 positive allosteric modulators with potential for the treatment of Parkinson's disease: WO09010455. Expert Opin Ther Pat. 2010 Mar;20(3):441-5. | ||||
| Ref 531039 | An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction. Bioorg Med Chem Lett. 2010 Aug 15;20(16):4901-5. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.